Sunday, 28 September

Expand All

8:00 - 12:00

Health Technology Assessment for Rare Diseases

Short Courses

Introduction to Applied Generative AI for HEOR

Short Courses

13:00 - 17:00

Causal Inference and Causal Estimands From Target Trial Emulations Using Evidence From Real-World Observational Studies and Clinical Trials

Short Courses

Critical Steps to Construct a Budget Impact Analysis

Short Courses

Monday, 29 September

8:00 - 9:15

Realizing RWE Potential in Asia Pacific: Opportunities, Challenges, and Progress

Plenary

9:15 - 9:45

Networking Break

General Meeting Events

9:45 - 10:45

Harnessing RWD for Evidence-Based HTA in Asia-Pacific: Data Challenges, Evolving Paradigms and Empirical Applications

Workshops

Translating Real-World Evidence Into Policy: A Comparative Analysis of Adoption Mechanisms in China and the US Drug Price Negotiations

Issue Panels

Fit for Purpose Data in Value Assessment in Japan: How Best to Leverage Real-World Evidence (RWE) and Qualitative Value Elements to Optimize Decision Analysis

Issue Panels

10:45 - 11:15

Networking Break

General Meeting Events

11:15 - 12:15

HTA System in Japan: Progress and Issues

Other Breakout Sessions

Equity-Informative Real-World Evidence: Learning From Global Lessons and Exploring Future Initiatives

Workshops

Harnessing Big Data, AI, and Real-World Evidence to Transform Regulatory and Health Technology Assessment in APAC

Issue Panels

12:15 - 13:15

Lunch

General Meeting Events

13:15 - 14:15

Informing Health Policy Decisions Through Meta-Analysis of Economic Evaluations: Why and How to Do It? How to Connect with Users?

Other Breakout Sessions

Learning From the COVID-19 Pandemic and Designing a New HEOR Research Model: What is the Role of Real-World Evidence and How Does It Work?

Other Breakout Sessions

Nordic-Asia Pacific Collaboration in Real-World Evidence Studies: Lessons Learnt and Opportunities for Future Research Networks

Workshops

14:15 - 15:15

Poster Session

General Meeting Events

Poster Session 1

Research Posters

15:15 - 16:15

How to Collect PROs in RW Studies and Leverage Them for Robust Evidence Generation? ISPOR Good Practices Task Force on Patient Reported Outcomes (PROs) in Prospective Real-World Studies: Emerging Recommendations & Next Steps

Workshops

Use of Real-World Evidence in Medical Device HTA Evaluations: Lessons Learned From Australia and Japan

Other Breakout Sessions

Enhancing Expert Education in HTA: Challenges and Lessons From Thailand

Workshops

16:15 - 16:45

Networking Break

General Meeting Events

16:45 - 17:45

Educational Symposia

General Meeting Events

17:45 - 18:45

Networking Reception

General Meeting Events

Tuesday, 30 September

8:00 - 9:00

Generative AI in RWE: Real-World Impact and the Road to Reliable Evidence for Decision Making

Workshops

The Promise of OMOP and Database Research at Scale in APAC: Opportunities and Gaps

Issue Panels

How to Address Evidence Uncertainties via Real-World Evidence Generation in Cancer Drug Fund in Taiwan

Issue Panels

9:00 - 9:30

Networking Break

General Meeting Events

9:30 - 10:30

Culture-Specific Health-Related Quality of Life Measurement: Is It Necessary for Asia?

Issue Panels

Real-World Evidence in China: How Can It Transform China's Healthcare Landscape?

Other Breakout Sessions

How Is Real-World Evidence Supporting Conditional Listing and Health Technology Reassessment?

Workshops

10:30 - 11:00

Networking Break

General Meeting Events

11:00 - 12:00

Educational Symposia

General Meeting Events

12:00 - 13:00

Networking Break

General Meeting Events

13:00 - 14:00

Poster Session

General Meeting Events

Poster Session 2

Research Posters

14:00 - 15:00

ISPOR-HTAsiaLink Joint Spotlight Session

General Meeting Events

15:00 - 15:15

Break

General Meeting Events

15:15 - 16:30

Building the Future: Advancing Real-World Evidence in Asia Pacific and Beyond

Plenary
Back to Top